AbbVie Inc (ABBV)
162.55
-0.18
(-0.11%)
USD |
NYSE |
May 07, 16:00
162.35
-0.20
(-0.12%)
Pre-Market: 08:38
AbbVie Price to Book Value: 35.85 for May 7, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 07, 2024 | 35.85 |
| May 06, 2024 | 35.89 |
| May 03, 2024 | 36.12 |
| May 02, 2024 | 35.47 |
| May 01, 2024 | 35.67 |
| April 30, 2024 | 35.87 |
| April 29, 2024 | 35.62 |
| April 26, 2024 | 35.20 |
| April 25, 2024 | 36.89 |
| April 24, 2024 | 37.00 |
| April 23, 2024 | 37.39 |
| April 22, 2024 | 37.02 |
| April 19, 2024 | 36.70 |
| April 18, 2024 | 36.31 |
| April 17, 2024 | 36.22 |
| April 16, 2024 | 35.84 |
| April 15, 2024 | 35.65 |
| April 12, 2024 | 35.79 |
| April 11, 2024 | 36.94 |
| April 10, 2024 | 37.27 |
| April 09, 2024 | 37.52 |
| April 08, 2024 | 37.44 |
| April 05, 2024 | 37.49 |
| April 04, 2024 | 37.03 |
| April 03, 2024 | 39.11 |
| Date | Value |
|---|---|
| April 02, 2024 | 39.85 |
| April 01, 2024 | 39.86 |
| March 31, 2024 | |
| March 28, 2024 | 31.12 |
| March 27, 2024 | 30.82 |
| March 26, 2024 | 30.63 |
| March 25, 2024 | 30.51 |
| March 22, 2024 | 30.50 |
| March 21, 2024 | 30.34 |
| March 20, 2024 | 30.13 |
| March 19, 2024 | 30.71 |
| March 18, 2024 | 30.51 |
| March 15, 2024 | 30.40 |
| March 14, 2024 | 30.97 |
| March 13, 2024 | 30.74 |
| March 12, 2024 | 30.92 |
| March 11, 2024 | 30.70 |
| March 08, 2024 | 30.57 |
| March 07, 2024 | 30.86 |
| March 06, 2024 | 30.95 |
| March 05, 2024 | 30.62 |
| March 04, 2024 | 30.26 |
| March 01, 2024 | 30.51 |
| February 29, 2024 | 30.02 |
| February 28, 2024 | 30.35 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
9.306
Minimum
Oct 28 2020
39.86
Maximum
Apr 01 2024
17.60
Average
16.45
Median
Price to Book Value Benchmarks
| Amgen Inc | 32.09 |
| Johnson & Johnson | 5.112 |
| Eli Lilly and Co | 57.69 |
| Merck & Co Inc | 8.181 |
| Pfizer Inc | 1.767 |
Price to Book Value Related Metrics
| PE Ratio | 48.23 |
| PS Ratio | 5.297 |
| Price to Free Cash Flow | 13.16 |
| Price | 162.55 |
| Earnings Yield | 2.07% |
| Market Cap | 287.04B |
| Operating PE Ratio | 21.22 |
| Normalized PE Ratio | 43.27 |